GlassScriptPhysician profile
Melody Adler
NPI 1760558977
$1,704.71
in general payments reported to CMS, 2019-2025
26 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2020: $37.09 · 2022: $296 · 2023: $341 · 2024: $300 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $144.66 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $141.82 | 2022-2025 | Slynd |
| Sumitomo Pharma America, INC. | $125.96 | 2023-2025 | Myfembree |
| Daiichi Sankyo INC. | $120.27 | 2019-2025 | Injectafer |
| Organon LLC | $114.04 | 2022-2025 | Nexplanon |
| Abbvie INC. | $111.57 | 2019-2022 | |
| Minerva Surgical, INC | $107.09 | 2019-2024 | |
| Hologic Sales and Service, LLC | $101.94 | 2019-2024 | Novasure, Myosure Tissue Removal Device |
| Coopersurgical, INC. | $92.25 | 2019-2025 | Paragard T 380a, Ally II Ups |
| Roche Diagnostics Corporation | $84.73 | 2019 | |
| Biogen, INC. | $80.99 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $71.51 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $68.30 | 2019-2025 | |
| Mycovia Pharmaceuticals, INC. | $40.23 | 2022-2023 | Vivjoa |
| Myovant Sciences INC. | $39.58 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $39.36 | 2024-2025 | Femring, Intrarosa, Femlyv |
| Mayne Pharma Commercial LLC | $36.77 | 2023-2025 | |
| Mylan Pharmaceuticals INC. | $33.59 | 2019 | |
| Amag Pharmaceuticals, INC. | $27.55 | 2019 | |
| Meditrina | $27.14 | 2024 | |
| Avion Pharmaceuticals | $23.97 | 2019 | |
| Inari Medical, INC. | $17.78 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Karl Storz Endoscopy-America | $14.23 | 2019 | |
| Merck Sharp & Dohme LLC | $14.03 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.82 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melody Adler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.